Hepatitis C treatments don't seem to work as well in African Americans

Hepatitis C treatments don't seem to work as well in African Americans...as in other racial and ethnic groups.

Peginterferon alfa-2b (PEG-Intron) and ribavirin (Rebetol) is effective in 52% of whites...but only 19% of African Americans.

Researchers used to think the difference was due to the type of hepatitis C virus that's more common in African Americans...but now researchers are rethinking this theory.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote